Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May 8:1:29.
doi: 10.3410/M1-29.

Impulse control disorders in Parkinson's disease

Affiliations

Impulse control disorders in Parkinson's disease

Mark Stacy. F1000 Med Rep. .

Abstract

Since the original descriptions of hedonistic homeostatic dysregulation syndrome and pathological gambling in Parkinson's disease, impulse control disorders, such as compulsive spending, punding, or binge eating, are increasingly recognized. Although the term hedonistic homeostatic dysregulation syndrome has been supplanted by the concept of the dopamine dysregulation syndrome, the features of severe dyskinesias, cyclical mood disorder with hypomania or manic psychosis, and impairment of social and occupational functioning in the setting of increased intake of antiparkinson therapy remain. At this time, impulse control disorder is defined as maladaptive behaviors that emerge with disease progression and increasing antiparkinson medications. These behaviors may be disruptive, such as punding, or destructive, such as compulsive spending, gambling, binge eating, or hypersexuality.

PubMed Disclaimer

References

    1. Goodwin FK. Psychiatric side effects of levodopa in man. JAMA. 1971;218:1915–20. doi: 10.1001/jama.218.13.1915. - DOI - PubMed
    1. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology. 2003;61:422–3. - PubMed
    1. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol. 2005;62:1377–81. doi: 10.1001/archneur.62.9.noc50009. - DOI - PubMed
    2. F1000 Factor 3.0 Recommended

      Evaluated by Kent Berridge 26 Jul 05

    1. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol. 1989;12:375–83. doi: 10.1097/00002826-198910000-00002. - DOI - PubMed
    1. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord. 2006;21:524–9. doi: 10.1002/mds.20757. - DOI - PubMed